159 results on '"Barilaro, Alessandro"'
Search Results
2. Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis
3. Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents
4. Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation
5. Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
6. TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood
7. Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis
8. Polyneuropathy and monoclonal gammopathy of undetermined significance (MGUS); update of a clinical experience
9. Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis
10. Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report
11. Anti-MAG IgM: differences in antibody tests and correlation with clinical findings
12. Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management
13. Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study
14. Epidemiology of amyotrophic lateral sclerosis in the north east Tuscany in the 2018–2021 period
15. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies
16. Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report
17. Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation
18. Cerebral hemodynamic lateralization during memory tasks as assessed by functional transcranial Doppler (fTCD) sonography: Effects of gender and healthy aging
19. Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience
20. Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP Astrocytopathy
21. Autologous haematopoietic stem cell transplantation versus low‐dose immunosuppression in secondary–progressive multiple sclerosis
22. Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis
23. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
24. Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions
25. An emerging spectrum of autoimmune astrocythopathy: Beyond anti-GFAP antibodies
26. Effectiveness of autologous haematopoietic stem cell transplantation and conventional immunosuppression in secondary progressive multiple sclerosis: A retrospective propensity-matched case-control study
27. Post-infective neuromuscular hyperexcitability syndrome in a young man with cystic fibrosis: A case report
28. Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment
29. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution
30. Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis
31. Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis
32. Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis
33. MSJ902392_supplementary_material – Supplemental material for Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis
34. Efficacy of Azathioprine on Multiple Sclerosis New Brain Lesions Evaluated Using Magnetic Resonance Imaging
35. Treating the Different Phenotypes of Behcet's Syndrome
36. MSJ872889_supplemental_table – Supplemental material for Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience
37. Treating the Different Phenotypes of Behçet's Syndrome
38. A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet
39. Anti-MAG IgM: differences in antibody tests and correlation with clinical findings
40. Acute cerebellar ataxia: a rare Toscana Virus (TOSV) meningoencephalitis complication
41. Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience
42. Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation
43. Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis.
44. Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases
45. CSF/serum matrix metallopeptidase-9 ratio discriminates neuro Behçet from multiple sclerosis
46. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
47. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies : Central Vein Sign
48. Natural history of multiple sclerosis inflammatory brain lesions: a FLAIR and T1w post contrast MRI volumetric analysis (P4.357)
49. MRI characterization of the “central vein sign” in brain white matter lesions of patients with multiple sclerosis but possible “better explanation of the diagnosis” (P4.400)
50. Time Course of Multiple Sclerosis Lesions Visualized with MRI: Insight into Focal Pathology (P3.015)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.